Reversal of sensorimotor gating abnormalities in Fmr1 knockout mice carrying a human Fmr1 transgene.
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Fragile X syndrome is caused by a CGG trinucleotide repeat expansion of the FMR1 gene. Individuals with fragile X display several behavioral abnormalities including hyperactivity, social anxiety, autistic-like features, impaired cognitive processing, and impaired sensorimotor gating. The Fmr1KO mouse model of fragile X exhibits several related behavioral phenotypes such as increased activity and altered social interactions. Individuals with fragile X also have impaired sensorimotor gating as measured using the prepulse inhibition of startle response. The authors have recently shown that Fmr1KO mice with a yeast artificial chromosome containing the human FMR1 gene have corrected or overcorrected abnormal behaviors including hyperactivity and altered social interactions. Here the authors present results from a study examining abnormal sensorimotor gating in Fmr1KO mice. Consistent with previous findings, Fmr1KO mice have increased prepulse inhibition. The KO mice with the yeast artificial chromosome containing the human FMR1 gene had levels of prepulse inhibition comparable to WT mice, indicating not only a correction of this phenotype, but also clearly demonstrating that in mice levels of the fragile X mental retardation protein regulate sensorimotor gating.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the fragile X model lacking the Fmr1 gene, expression of a functional human FMR1 gene restored social behavior and sensory gating 37-39 .”
From Progress toward treatments for synaptic defects in autism (2013) · cites this paper as [38]
Citations
Cites
Fragile X Syndrome: Diagnosis, Treatment, And Research
Silverman, & Cronister, A. (1991) · Johns Hopkins University Press eBooks · Cited by 481
Cited by
Behavioural phenotyping assays for mouse models of autism
Silverman, J. L., Yang, M., Lord, C., & Crawley, J. N. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2851 · Cited by 1,462
Silverman, J. L., Tolu, S. S., Barkan, C. L., & Crawley, J. N. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.201 · Cited by 438
Modeling fragile X syndrome in the Fmr1 knockout mouse
Kazdoba, T. M., Leach, P. T., Silverman, J. L., & Crawley, J. N. (2014) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2014.01024 · Cited by 241
Spencer, C. M., Alekseyenko, O., Hamilton, S. M., Thomas, A. M., Serysheva, E., Yuva‐Paylor, L. A., & Paylor, R. (2011) · Autism Research · doi:10.1002/aur.168 · Cited by 215
“…hotplate response, which was not previously reported, many of these behaviors were observed previously in Fmr1KO mice on the congenic B6 background and have been shown to be (over)corrected in Fmr1KO mice expressing transgenic FMRP [Paylor et al., 2008; Peier et al., 2000; Spencer et al., 2008].”
BackgroundMethodResultInfluentialSelf-citationProgress toward treatments for synaptic defects in autism
Delorme, R., Ey, E., Toro, R., Leboyer, M., Gillberg, C., & Bourgeron, T. (2013) · Nature Medicine · doi:10.1038/nm.3193 · Cited by 218
Behavioral profiles of mouse models for autism spectrum disorders
Ey, E., Leblond, C. S., & Bourgeron, T. (2011) · Autism Research · doi:10.1002/aur.175 · Cited by 161
Genetic Models of Sensorimotor Gating: Relevance to Neuropsychiatric Disorders
Powell, S. B., Weber, M., & Geyer, M. A. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_195 · Cited by 137
“One such example is the FMR1 KO mice (Paylor et al. 2008; Thomas et al. 2011a, b; but see de Vrij et al. 2008; Table 2).”
BackgroundBaker, K. B., Wray, S. P., Ritter, R., Mason, S., Lanthorn, T. H., & Savelieva, K. V. (2010) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2010.00585.x · Cited by 106
“One of the more puzzling phenotypes reported in Fmr1 KO mice is an increase in sensory gating (PPI), in contrast to reductions in PPI noted in FXS patients (Frankland et al. 2004; Paylor et al. 2008).”
ResultTargeted treatments for fragile X syndrome
Berry-Kravis, E., Knox, A., & Hervey, C. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-011-9074-7 · Cited by 103
“…marble burying (Paylor 2008), abnormal social behaviors (Paylor 2008; Mines et al. 2010; Spencer et al. 2008), abnormal prepulse inhibition (PPI; Paylor et al. 2008; de Vrij et al. 2008), prolonged epileptiform bursts (Subrathan et al. 2010), neuronal network hyperexcitability (Gibson et al.…”
BackgroundThomas, A. M., Bui, N., Perkins, J. R., Yuva‐Paylor, L. A., & Paylor, R. E. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2375-4 · Cited by 115
“Although the baseline PPI and startle responses between WT and KO mice at the zero dose were consistent with what we (Paylor et al. 2008; Spencer et al. 2011) and others (Chen and Toth 2001; Frankland et al.”
BackgroundMethodResultInfluentialSelf-citationThe GABAAreceptor is an FMRP target with therapeutic potential in fragile X syndrome
Braat, S., D'Hulst, C., Heulens, I., De Rubeis, S., Mientjes, E., Nelson, D. L., Willemsen, R., Bagni, C., Van Dam, D., De Deyn, P. P., et al. (2015) · Cell Cycle · doi:10.4161/15384101.2014.989114 · Cited by 92
“After DNA isolation from mouse tails, genotyping was performed as previously described.(43)”
MethodSelf-citationNeural Mechanisms Underlying Repetitive Behaviors in Rodent Models of Autism Spectrum Disorders
Gandhi, T., & Lee, C. C. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.592710 · Cited by 88
“Gene therapy using human FRM1 alleviates the low pre-pulse inhibition, hyperactivity, and anxiety behaviors in Fmr1-KO mice (Peier et al., 2000; Paylor et al., 2008; Spencer et al., 2008; Gholizadeh et al., 2014).”
BackgroundDeLorey, T. M., Sahbaie, P., Hashemi, E., Li, W.-W., Salehi, A., & Clark, D. J. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.06.032 · Cited by 95
Thomas, A. M., Bui, N., Graham, D., Perkins, J. R., Yuva-Paylor, L. A., & Paylor, R. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.04.049 · Cited by 74
“Startle response and prepulse inhibition (PPI)—The prepulse inhibition test was used to study sensorimotor gating as previously described [35].”
MethodSelf-citationRepetitive behavior profile and supersensitivity to amphetamine in the C58/J mouse model of autism
Moy, S. S., Riddick, N. V., Nikolova, V. D., Teng, B. L., Agster, K. L., Nonneman, R. J., Young, N. B., Baker, L. K., Nadler, J. J., & Bodfish, J. W. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.10.052 · Cited by 68
“However, similar lower startle amplitudes and enhanced prepulse inhibition have been reported in heterozygous mice with deficient function of Gabrb3, a candidate gene for autism susceptibility [62], and in Fmr1-null mice, a model for fragile X syndrome [21,63,66,67].”
BackgroundVinueza Veloz, M. F., Buijsen, R. A. M., Willemsen, R., Cupido, A., Bosman, L. W. J., Koekkoek, S. K. E., Potters, J. W., Oostra, B. A., & De Zeeuw, C. I. (2012) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2011.00763.x · Cited by 65
“Moreover, different from other tests such as eyeblink conditioning, in which Fmr1 KO mice also show a phenotype (Chen & Toth 2001; Paylor et al. 2008; Spencer et al. 2006), the Erasmus Ladder test does not require any surgical intervention and allows drug screening at an automated, medium-throughput level.”
BackgroundFMRP Expression Levels in Mouse Central Nervous System Neurons Determine Behavioral Phenotype
Arsenault, J., Gholizadeh, S., Niibori, Y., Pacey, L. K. K., Halder, S. K., Koxhioni, E., Konno, A., Hirai, H., & Hampson, D. R. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.090 · Cited by 79
“Trials and settings were programmed as previously described.(27,28) Briefly, each session consisted of 48 trials divided into six blocks of eight pseudo-randomly presented conditions.”
Verma, V., Paul, A., Vishwanath, A. A., Vaidya, B., & Clement, J. P. (2019) · Open Biology · doi:10.1098/rsob.180265 · Cited by 72
Mouse Models of Autism: Testing Hypotheses About Molecular Mechanisms
Roullet, F., & Crawley, J. N. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_113 · Cited by 68
“…(2004), Bilousova et al. (2009), D’Hooge et al. (1997), Dolen et al. (2007), Errijgers et al. (2008), Lauterborn et al. (2007), Moon et al. (2006), Paylor et al. (2008), Peier et al. (2000), Spencer et al. (2005) Chr 15q11–13 Deletions and duplications in the 15q11–13 chromosomal region are…”
BackgroundMechanisms underlying auditory processing deficits in Fragile X syndrome
McCullagh, E. A., Rotschafer, S. E., Auerbach, B. D., Klug, A., Kaczmarek, L. K., Cramer, K. S., Kulesza, R. J., Razak, K. A., Lovelace, J. W., Lu, Y., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902435r · Cited by 71
Veeraragavan, S., Graham, D., Bui, N., Yuva-Paylor, L. A., Wess, J., & Paylor, R. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.11.018 · Cited by 58
Self-citationVeeraragavan, S., Bui, N., Perkins, J. R., Yuva‐Paylor, L. A., Carpenter, R. L., & Paylor, R. E. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2276-6 · Cited by 71
“Fmr1KO mice routinely display enhanced PPI and attenuated startle response (Chen and Toth 2001; Nielsen et al. 2002; Frankland et al. 2004; Paylor et al. 2008).”
BackgroundMethodSelf-citationLi, M., Zhao, H., Ananiev, G. E., Musser, M. T., Ness, K. H., Maglaque, D. L., Saha, K., Bhattacharyya, A., & Zhao, X. (2016) · Stem Cells · doi:10.1002/stem.2463 · Cited by 60
Hyperexcitability and homeostasis in fragile X Syndrome.
Liu, X., Kumar, V., Tsai, N.-P., & Auerbach, B. D. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.805929 · Cited by 53
“, 2006) and ASR phenotypes in FMR1 KO animals can be rescued with the reintroduction of the Fmr1 gene (Paylor et al., 2008), indicating that some aspects of the ASR are directly related to loss of FMRP.”
BackgroundResultDe Rubeis, S., Fernández, E., Buzzi, A., Di Marino, D., & Bagni, C. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-7091-0932-8_23 · Cited by 48
Kat, R., Arroyo-Araujo, M., de Vries, R. B. M., Koopmans, M. A., de Boer, S. F., & Kas, M. J. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104722 · Cited by 49
“Compensatory upregulation of FMRP-associated proteins in the KO mice may underlie the opposite phenotypes (Frankland et al., 2004; Paylor et al., 2008), as double mutant mice lacking both Fmr1 and FXR2 (FMR1 autosomal homolog 2) show decreased levels of PPI (Spencer et al., 2006).”
BackgroundChen, C., Pal, R., Yin, J., Tao, H., Amawi, A., Sabo, A., Bainbridge, M. N., Gibbs, R. A., Zoghbi, H. Y., & Schaaf, C. P. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddz305 · Cited by 41
“PPI test was used to assess schizophrenia-associated behavior in mice as previously described with few modifications (25).”
MethodRobust and replicable measurement for prepulse inhibition of the acoustic startle response
Miller, E. A., Kastner, D. B., Grzybowski, M. N., Dwinell, M. R., Geurts, A. M., & Frank, L. M. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0703-y · Cited by 40
The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide.
Veeraragavan, S., Bui, N., Perkins, J. R., Yuva-Paylor, L. A., & Paylor, R. (2011) · Behavioral Neuroscience · doi:10.1037/a0025202 · Cited by 34
“Previous studies have reported a decrease in startle response and an enhanced PPI response in the FmrIKO (Chen & Toth, 2001; Frankland et al., 2004; Nielsen et al., 2002; Paylor et al., 2008).”
Self-citationAutism and EMF? Plausibility of a pathophysiological link – Part I
Herbert, M. R., & Sage, C. (2013) · Pathophysiology · doi:10.1016/j.pathophys.2013.08.001 · Cited by 42
“There are growing numers of reports of improvement and loss of diagnosis, reversal f neurological symptoms in a growing number of mouse odels of genetic syndromes that in humans prominently eature autism [52–62], short-term pharmaceutically-induced w t s A iology 20 (2013) 191–209 193”
Thomas, A. M., Schwartz, M. D., Saxe, M., & Kilduff, T. S. (2017) · SLEEP · doi:10.1093/sleep/zsx138 · Cited by 37
“Startle Response and Prepulse Inhibition Sensorimotor gating and startle responses(32) were studied at 25 weeks of age using the SR-LAB startle response system (San Diego Instruments, San Diego, CA) as previously described.(33,34) Rats were placed in clear, cylindrical holding tubes within a sound attenuating chamber…”
MethodCharacterization of Auditory and Binaural Spatial Hearing in a Fragile X Syndrome Mouse Model
McCullagh, E. A., Poleg, S., Greene, N. T., Huntsman, M. M., Tollin, D. J., & Klug, A. (2020) · eNeuro · doi:10.1523/eneuro.0300-19.2019 · Cited by 27
“In contrast to PPI and ASR responses that differed between Fmr1 and B6 mice, where we saw specific impairments under certain conditions, there was an overall trend for Fmr1 mice to have increased latency to startle under a variety of conditions.”
BackgroundResultInfluentialBehavioural characterization of AnkyrinG deficient mice, a model for ANK3 related disorders
van der Werf, I. M., Dam, D. V., Missault, S., Yalcin, B., Deyn, P. P. D., Vandeweyer, G., & Kooy, R. F. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.04.014 · Cited by 25
“Acoustic startle and prepulse inhibition Acoustic startle response and prepulse inhibition (PPI) of startle were assessed as previously described with minor adaptations [20].”
Neklyudova, A. K., Smirnov, K., Rebreikina, A. B., Martynova, O., & Sysoeva, O. (2022) · Genes · doi:10.3390/genes13040671 · Cited by 26
“Mice models of Fragile X syndrome also present impairments in sensory processing in visual [76], auditory [77,78], and sensorimotor modality [79], with the frequent occurrence of hypersensitive behavior, such as a higher susceptibility to seizures in response to auditory stimuli, and defensive behavior to repetitive w…”
BackgroundImpaired sensorimotor gating in Fmr1 knock out and Fragile X premutation model mice
Renoux, A. J., Sala‐Hamrick, K., Carducci, N. M., Frazer, M. A., Halsey, K. E., Sutton, M. A., Dolan, D. F., Murphy, G. G., & Todd, P. K. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.03.013 · Cited by 21
Zhou, H., Wu, W., Zhang, Y., He, H., Yuan, Z., Zhu, Z.-W., & Zhao, Z. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.01.023 · Cited by 21
Fernández, J. J., Martínez, R., Andújar, E., Pérez-Alegre, M., Costa, A. F., Bonilla, V., Sobrino, F., Pintado, C. O., & Pintado, E. (2012) · Genetics and Molecular Research · doi:10.4238/2012.march.1.4 · Cited by 9
“…been reported that overexpression of the FMR1 gene with CGG in the normal range does not rescue the fragile X phenotype in KO mouse (Bakker et al., 2000) although a reversal of sensomotor gating abnormalities in the KO mice carrying a human FMR1 transgene has been described (Paylor et al., 2008).”
BackgroundO’Leary, H., & Benke, T. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804066-9.00074-2 · Cited by 2
Genetic and Pharmacological Reversibility of Phenotypes in Mouse Models of Autism Spectrum Disorder
Schroeder, J. C., Deliu, E., Novarino, G., & Schmeißer, M. J. (2017) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-319-52498-6_10 · Cited by 2
Neurodevelopmental Toxicology and Autism Spectrum Disorders
Berman, R. F., Koenig, C. M., Hunsaker, M. R., Pessah, I. N., & LaSalle, J. M. (2010) · Wiley eBooks · doi:10.1002/9780470917060.ch21
Mouse Behavioral Models for Autism Spectrum Disorders
Wetsel, W. C., Moy, S. S., & Jiang, Y.-H. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391924-3.00026-0
Virus-mediated Delivery of the Fmr1 Gene as a Tool for the Treatment of Fragile X Syndrome
Moghaddam, S. G. (2016) · TSpace (University of Toronto)
Modelling fragile X syndrome in rats: new directions in translational research
Asiminas, A. (2017) · ERA · Cited by 1
From replicability to generalizability: how research practice can shape scientific results
Arroyo-Araujo, M. (2022) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.325014460
Houbaert, X. (2014) · theses.fr (ABES) · doi:10.70675/e01f6a8dze8a0z4d04z90e1z3d1812752374
“Expression of a human form of FMR1 gene in Fmr1 KO mice restored social behavior and sensory gating (Paylor et al., 2008; Spencer et al., 2008).”
BackgroundPaluszkiewicz, S. M. (2011) · DigitalGeorgetown (Georgetown University Library)
Metadata
- Authors
- Paylor, R., Yuva-Paylor, L. A., Nelson, D. L., & Spencer, C. M.
- Affiliations
- Baylor College of Medicine (US)
- Venue
- Behavioral Neuroscience
- Published
- 2008-12
- Volume
- 122
- Issue
- 6
- Pages
- 1371-1377
- ISSN
- 0735-7044 (ISSN-L)
- 1939-0084
- OpenAlex
- W2052824465
- Cited by
- 46
- References
- 1
- Citations by year
- 2022: 3 · 2021: 1 · 2020: 4 · 2019: 2 · 2017: 5 · 2016: 3 · 2015: 1 · 2014: 3 · 2013: 3 · 2012: 5
- FWCI
- 3.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Behavioral Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- MRDDRC
- Baylor College of Medicine
- FRAXA Research Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Keywords
- fragile X syndrome, FMR1 gene, Fmr1 knockout mice, sensorimotor gating, prepulse inhibition, startle response, FMRP, hyperactivity, social interaction, CGG repeat expansion
- MeSH terms
- Acoustic Stimulation, Animals, Behavior, Animal, Genotype, Humans, Mice, Inbred C57BL, Mice, Transgenic, Neural Inhibition, Psychophysics, Reaction Time, Mice, Fragile X Messenger Ribonucleoprotein 1, Fragile X Mental Retardation Protein, Sensory Gating
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.